PH12019501950A1 - Intradialytic use of sodium nitrite - Google Patents
Intradialytic use of sodium nitriteInfo
- Publication number
- PH12019501950A1 PH12019501950A1 PH12019501950A PH12019501950A PH12019501950A1 PH 12019501950 A1 PH12019501950 A1 PH 12019501950A1 PH 12019501950 A PH12019501950 A PH 12019501950A PH 12019501950 A PH12019501950 A PH 12019501950A PH 12019501950 A1 PH12019501950 A1 PH 12019501950A1
- Authority
- PH
- Philippines
- Prior art keywords
- sodium nitrite
- intradialytic
- methods
- nitrite
- subject undergoing
- Prior art date
Links
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 title abstract 4
- 235000010288 sodium nitrite Nutrition 0.000 title abstract 2
- 238000001631 haemodialysis Methods 0.000 abstract 2
- 230000000322 hemodialysis Effects 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
- A61M1/1656—Apparatus for preparing dialysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- External Artificial Organs (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762468857P | 2017-03-08 | 2017-03-08 | |
| PCT/US2018/021053 WO2018165098A1 (en) | 2017-03-08 | 2018-03-06 | Intradialytic use of sodium nitrite |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH12019501950A1 true PH12019501950A1 (en) | 2020-06-15 |
Family
ID=63445965
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH12019501950A PH12019501950A1 (en) | 2017-03-08 | 2019-08-23 | Intradialytic use of sodium nitrite |
Country Status (15)
| Country | Link |
|---|---|
| US (5) | US10328099B2 (enExample) |
| EP (2) | EP3592342B1 (enExample) |
| JP (3) | JP7314050B2 (enExample) |
| KR (4) | KR102647803B1 (enExample) |
| AR (1) | AR111166A1 (enExample) |
| AU (2) | AU2018231016B2 (enExample) |
| BR (1) | BR112019018861A2 (enExample) |
| CA (1) | CA3055105A1 (enExample) |
| ES (1) | ES2986444T3 (enExample) |
| IL (4) | IL301302B2 (enExample) |
| NZ (1) | NZ756701A (enExample) |
| PH (1) | PH12019501950A1 (enExample) |
| TW (3) | TWI798203B (enExample) |
| WO (1) | WO2018165098A1 (enExample) |
| ZA (3) | ZA201905679B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL301302B2 (en) | 2017-03-08 | 2024-09-01 | Hope Medical Entpr Inc Dba Hope Pharmaceuticals | Intradialytic use of sodium nitrite |
| ES2992792T3 (en) | 2017-03-08 | 2024-12-18 | Hope Medical Entpr Inc D B A Hope Pharmaceuticals | Intradialytic use of sodium thiosulfate |
| KR102875863B1 (ko) * | 2019-07-22 | 2025-10-23 | 스쿨 주리디칼 퍼슨 키타사토 인스티튜트 | 투석 장치 |
| US20230149732A1 (en) * | 2021-11-17 | 2023-05-18 | Wake Forest University Health Sciences | Combined nitrite and light treatment to prevent device thrombosis |
| US12128166B2 (en) | 2022-12-16 | 2024-10-29 | Fresenius Medical Care Holdings, Inc. | Systems and methods for using nitric oxide in dialysis |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1341151C (en) | 1985-09-10 | 2000-12-05 | Elias Klein | Osmotic agents form peritoneal dialysis |
| US6380163B1 (en) | 1992-12-22 | 2002-04-30 | Baxter International Inc. | Peritoneal dialysis solutions with polypeptides |
| FI98538C (fi) | 1993-10-20 | 1997-07-10 | Enso Gutzeit Oy | Menetelmä natriumhydroksidin valmistamiseksi valkolipeästä |
| US6306836B1 (en) | 1994-01-21 | 2001-10-23 | Baxter International Inc. | Peritoneal dialysis solutions containing maltodextrins and amino acids |
| US6436969B1 (en) | 1995-09-12 | 2002-08-20 | Kansas University Medical Center Research Institute Inc. | Dialysis solutions and methods |
| JP4882054B2 (ja) | 2000-09-13 | 2012-02-22 | 独立行政法人科学技術振興機構 | 腹膜透析液およびその調製法 |
| CA2537222A1 (en) * | 2003-07-09 | 2005-01-27 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Use of nitrite salts for the treatment of cardiovascular conditions |
| US7362274B1 (en) * | 2004-07-09 | 2008-04-22 | Huan-Cheng Lien | Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna |
| US20070154570A1 (en) * | 2004-09-29 | 2007-07-05 | Miller Christopher C | Use of nitric oxide in the treatment and disinfection of biofilms |
| US7547637B2 (en) * | 2005-06-21 | 2009-06-16 | Intel Corporation | Methods for patterning a semiconductor film |
| US20090304600A1 (en) | 2008-06-09 | 2009-12-10 | Anupkumar Shetty | Intradialytic administration of sodium thiosulfate |
| US8568793B2 (en) | 2009-02-11 | 2013-10-29 | Hope Medical Enterprises, Inc. | Sodium nitrite-containing pharmaceutical compositions |
| DK2451435T4 (da) | 2009-07-08 | 2022-02-28 | Hope Medical Entpr Inc D B A Hope Pharmaceuticals | Natriumthiosulfat-indeholdende farmaceutiske sammensætninger |
| WO2013023217A1 (en) * | 2011-08-11 | 2013-02-14 | Board Of Regents, The University Of Texas System | Method of measuring and monitoring in vivo nitrite levels |
| AU2013212264B2 (en) | 2012-01-23 | 2017-05-18 | Santalis Pharmaceuticals Inc. | Sandalwood oil and its uses related to clostridium infections |
| JP5486069B1 (ja) | 2012-11-05 | 2014-05-07 | 旭 酒井 | 透析装置 |
| US20140350097A1 (en) | 2013-05-23 | 2014-11-27 | Medinox,Inc. | Treatment of hypotension associated with hemodialysis |
| JP6183832B2 (ja) | 2013-06-19 | 2017-08-23 | 扶桑薬品工業株式会社 | 酸化ストレス抑制型透析用剤およびその調製方法 |
| IL301302B2 (en) | 2017-03-08 | 2024-09-01 | Hope Medical Entpr Inc Dba Hope Pharmaceuticals | Intradialytic use of sodium nitrite |
-
2018
- 2018-03-06 IL IL301302A patent/IL301302B2/en unknown
- 2018-03-06 EP EP18763384.7A patent/EP3592342B1/en active Active
- 2018-03-06 CA CA3055105A patent/CA3055105A1/en active Pending
- 2018-03-06 KR KR1020197029157A patent/KR102647803B1/ko active Active
- 2018-03-06 BR BR112019018861A patent/BR112019018861A2/pt unknown
- 2018-03-06 EP EP24182318.6A patent/EP4406595A3/en active Pending
- 2018-03-06 IL IL312092A patent/IL312092B2/en unknown
- 2018-03-06 AU AU2018231016A patent/AU2018231016B2/en active Active
- 2018-03-06 KR KR1020247008154A patent/KR102706379B1/ko active Active
- 2018-03-06 KR KR1020257002477A patent/KR20250017763A/ko active Pending
- 2018-03-06 JP JP2019548431A patent/JP7314050B2/ja active Active
- 2018-03-06 KR KR1020247030224A patent/KR102760913B1/ko active Active
- 2018-03-06 ES ES18763384T patent/ES2986444T3/es active Active
- 2018-03-06 WO PCT/US2018/021053 patent/WO2018165098A1/en not_active Ceased
- 2018-03-06 NZ NZ756701A patent/NZ756701A/en unknown
- 2018-03-07 US US15/914,353 patent/US10328099B2/en active Active
- 2018-03-07 TW TW107107745A patent/TWI798203B/zh active
- 2018-03-07 TW TW113105276A patent/TWI888012B/zh active
- 2018-03-07 AR ARP180100529A patent/AR111166A1/es not_active Application Discontinuation
- 2018-03-07 TW TW112109906A patent/TWI835595B/zh active
-
2019
- 2019-05-03 US US16/403,428 patent/US10898512B2/en active Active
- 2019-08-23 IL IL268882A patent/IL268882B/en unknown
- 2019-08-23 PH PH12019501950A patent/PH12019501950A1/en unknown
- 2019-08-28 ZA ZA2019/05679A patent/ZA201905679B/en unknown
-
2020
- 2020-11-23 US US17/102,411 patent/US11564938B2/en active Active
-
2021
- 2021-07-07 IL IL284684A patent/IL284684B2/en unknown
-
2022
- 2022-07-29 ZA ZA2022/08504A patent/ZA202208504B/en unknown
-
2023
- 2023-01-03 US US18/092,569 patent/US12011456B2/en active Active
- 2023-07-12 JP JP2023114331A patent/JP7551858B2/ja active Active
- 2023-07-25 ZA ZA2023/07367A patent/ZA202307367B/en unknown
-
2024
- 2024-05-08 US US18/658,338 patent/US20240285677A1/en active Pending
- 2024-05-28 AU AU2024203535A patent/AU2024203535A1/en active Pending
- 2024-09-04 JP JP2024152352A patent/JP7765687B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202307367B (en) | Intradialytic use of sodium nitrite | |
| ZA202209104B (en) | Intradialytic use of sodium thiosulfate | |
| MX2021002321A (es) | Nuevos metodos. | |
| MX2015017201A (es) | Derivados de pirazolopiridina para uso en el tratamiento del cancer de vejiga. | |
| MY186977A (en) | Tetrasubstituted alkene compounds and their use | |
| PH12016502355A1 (en) | Pharmaceutical composition | |
| MY174727A (en) | Stable, protracted glp-1/glucagon receptor co-agonists for medical use | |
| MX2017000366A (es) | Terapia de combinacion para el cancer. | |
| TW201613578A (en) | Pharmaceutical combinations | |
| PH12016502352A1 (en) | Pharmaceutical composition | |
| MX376029B (es) | Compuestos de isoindol. | |
| PH12021551235A1 (en) | Elacestrant in combination with abemaciclib in women with breast cancer | |
| MX2016016388A (es) | Uso de compuestos de tienotriazolodiazepina para el tratamiento de cancer de pulmon de celula no pequeña y/o cancer de pulmon de celula pequeña. | |
| WO2014071168A3 (en) | Administering inhibitors of tgfbeta signaling to improve muscle function in cancer patients | |
| PH12016502233A1 (en) | (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine | |
| PH12014500381A1 (en) | Therapeutic methods | |
| MX2015014939A (es) | Nuevo uso de clorhidrato de landiolol en el tratamiento a largo plazo de taquiarritmias e hipertension. | |
| MX2017015664A (es) | Administracion intravenosa de citrulina durante cirugia. | |
| MX2023001425A (es) | Inhibidores de cinasa de insercion proviral en linfomas murinos (pim) para el tratamiento de neoplasias mieloproliferativas y fibrosis asociadas con cancer. | |
| MA39599A (fr) | Dosage et administration d'agents thérapeutiques anti-egfr | |
| MY195767A (en) | Treatment of Androgen Deprivation Therapy Associated Symptoms | |
| EA201590760A1 (ru) | Применение бремеланотида в терапии женской сексуальной дисфункции | |
| MX2020006451A (es) | Tratamiento de la fibrosis con inositol. | |
| UA69624U (uk) | Спосіб профілактики загострення хронічного бронхіту у хворих зі сполученим перебігом з пептичною виразкою дванадцятипалої кишки | |
| UA100902U (uk) | Спосіб лікування мікрогландулярної гіперплазії шийки матки у жінок із порушеннями вегетативного гомеостазу |